CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Anhui Anke Biotechnology (Group) Company., Limited Company Snapshot
Anhui Anke Biotechnology (Group) Company., Limited operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Anhui Anke Biotechnology (Group) Company., Limited with three other companies in this sector in CHINA : Shenzhen Kangtai Biological Products Co Ltd (2019 sales of 1.94 billion Chinese Renmimbi [US$278.89 million] of which 100% was Biological products), Tianjin Ringpu Bio-Technology Co Ltd (1.47 billion Chinese Renmimbi [US$210.47 million] of which 57% was Veterinary Biological Products), and Beijing SL Pharmaceutical Co Ltd (2.03 billion Chinese Renmimbi [US$291.28 million] of which 99% was Pharmaceuticals Industry).

Sales Analysis. During the year ended December of 2019, sales at Anhui Anke Biotechnology (Group) Company., Limited were 1.71 billion Chinese Renmimbi (US$245.77 million). This is an increase of 17.2% versus 2018, when the company's sales were 1.46 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Anhui Anke Biotechnology (Group) Company., Limited (and since 2014, sales have increased a total of 216%). Sales of Technical Services saw an increase that was more than double the company's growth rate: sales were up 130.6% in 2019, from 57.16 million Chinese Renmimbi to 131.83 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Anhui Anke Biotechnology (Group) Company., Limited
  Stock Performance Chart for Anhui Anke Biotechnology (Group) Company., Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (8/7/2020): 19.11
(Figures in Chinese Renmimbi)
1 Week -9.7%   13 Weeks -1.9%  
4 Weeks 11.8%   52 Weeks 29.2%  
 
Anhui Anke Biotechnology (Group) Company., Limited Key Data:
  Ticker: 300009 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 1,712,529,669
(Year Ending Jan 2020).
Employees: 2,295
  Currency: Chinese Renmimbi Market Cap: 26,092,564,021
  Fiscal Yr Ends: December Shares Outstanding: 1,365,387,966
  Share Type: A Gu Closely Held Shares:
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.